Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research interests include HIV, Drug Use, Sexual Risk, Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes, and HIV/AIDS Research and Interventions.
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement
Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020
Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts
Responding to a surge in overdose deaths: perspectives from US syringe services programs
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives
M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
Ending the HIV epidemic in the USA: an economic modelling study in six cities
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
“Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities
How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value
Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities